1. The effects of salicylate on oxidative phosphorylation and respiration were investigated in liver and brain mitochondria, and in sonically prepared mitochondrial fragments. 2. Salicylate was shown to uncouple oxidative phosphorylation in mitochondrial fragments, as well as in intact mitochondria. The effects of salicylate on mitochondria and oxidative phosphorylation resemble those produced by dinitrophenol. 3. The quantitative effects of salicylate on respiration in vitro were shown to be complex. The final effect may be the resultant of an interaction of a multiplicity of factors, such as the tissue, the substrate, mitochondrial and extramitochondrial influences, and the direct effect on the respiratory chain itself.
1. The effects of salicylate on oxidative phosphorylation and respiration were investigated in liver and brain mitochondria, and in sonically prepared mitochondrial fragments. 2. Salicylate was shown to uncouple oxidative phosphorylation in mitochondrial fragments, as well as in intact mitochondria. The effects of salicylate on mitochondria and oxidative phosphorylation resemble those produced by dinitrophenol. 3. The quantitative effects of salicylate on respiration in vitro were shown to be complex. The final effect may be the resultant of an interaction of a multiplicity of factors, such as the tissue, the substrate, mitochondrial and extramitochondrial influences, and the direct effect on the respiratory chain itself. Brody (1956) reported that salicylate uncouples oxidative phosphorylation; subsequently many investigators have studied the uncoupling effect of the drug. This influence on energy metabolism is employed to explain some of the clinical effects and untoward manifestations associated with salicylate therapy (Brody, 1956; Whitehouse, 1964) . The exact mechanism of the uncoupling, as well as the primary subcellular site of action, however, has yet to be defined unequivocally. For example, Falcone (1959) reported that salicylate stimulated mitochondrial adenosine-triphosphatase activity, and Charnock & Opit (1962) observed that salicylate facilitates the enzymic breakdown of ATP by affecting the permeability of the mitochondrial membrane. From these observations, it is conceivable that the salicylate-induced uncoupling is the consequence of an elevated adenosine-triphosphatase activity and is mediated by alterations in the structure of the mitochondrion (Charnock & Opit, 1962) .
Other evidence, however, indicates that salicylate may uncouple by a direct action on the oxidative-phosphorylation reactions. Jeffrey & Smith (1959) found that salicylate, like 2,4-dinitrophenol, retards mitochondrial swelling. Similarly, Penniall (1958) demonstrated that salicylate, again like dinitrophenol, uncouples at each phosphorylation site. When such observations are considered in the light of current concepts of the direct action of dinitrophenol on phosphorylation, there is some support for the interpretation that salicylate also uncouples by a direct action on the phosphorylation process.
The approach in the present study was to compare the effect of salicylate on intact mitochondria with the effect on a simpler model, namely, mitochondrial fragments prepared by sonic disruption. These fragment preparations, resistant to the uncoupling action of Ca2+ (McMurray, Maley & Lardy, 1958) and 1mM-thyroxine (J. T. Miyahara & R. Karler, unpublished work), provided an opportunity to determine whether the uncoupling action of salicylate requires the presence of an intact mitochondrial membrane or whether the action is of a direct nature on the enzyme system present in the mitochondrial fragments. In addition to the phosphorylation experiments, the effect of salicylate on the oxidation rate of various substrates was compared in both intact mitochondria and mitochondrial fragments from liver and brain.
METHODS
Liver and brain mitochondria were isolated from adult male Sprague-Dawley rats by differential centrifugation (Karler, Sulkowski & Miyahara, 1965 
RESULTS
Effect of 8alicylate on oxidative pho8phorylation and re8piration of liver mitochondria. Table 1 shows salicylate effects on liver mitochondria oxidizing pyruvate, succinate and fl-hydroxybutyrate respectively. As reported by others and shown in Table 1 , there is a direct relation between drug concentration and effect on the uptake of inorganic phosphate and on the P/O ratio for all three substrates studied. A low concentration of salicylate (0-01 mM) slightly affected phosphorylation and the P/O ratio, whereas a high concentration (lmm) markedly decreased both values. Oxidative phosphorylation was completely uncoupled by 10mm-salicylate irrespective of substrate. The additional phosphate liberated (shown as negative uptake in Table 1 ) at these high concentrations of salicylate probably resulted from the breakdown of the added ATP. The oxidation of pyruvate and succinate by liver mitochondria was significantly depressed by 1 mM-salicylate, whereas oxygen consumption of liver mitochondria with fl-hydroxybutyrate as substrate was not affected to the same degree at this concentration.
Effect of 8alicylate on oxidative pho8phorylation
and respiration in brain mitochondria. Results of experiments conducted on brain mitochondria are illustrated in Table 2 . As with liver, phosphorylation and P/O ratios were similarly affected by salicylate in that both were decreased by increasing salicylate concentrations. Complete uncoupling and increase of inorganic phosphate concentration were also observed at 10mlim concentration. The effect on respiration of brain mitochondria, however, differed from that seen with liver preparations.
As reported by Brody (1956) , a salicylate concentration (10mm) that completely dissociated oxidation from phosphorylation stimulated oxygen utilization in brain when pyruvate was the sub- Vol. 97 Table 3 , both the uptake of inorganic phosphate and the P/O ratio were markedly depressed by 0 1 mM-salicylate. Moreover, complete uncoupling of oxidative phosphorylation was observed at a concentration of 1 mm, compared with 10mM for a similar effect with non-disrupted mitochondria. The effect of salicylate on liver mitochondrial respiration is included in Table 3 . With f-hydroxybutyrate as substrate, a low concentration (0O01mM) of salicylate enhanced oxygen consumption, whereas with succinate as substrate the same concentration had practically no effect on the rate of oxygen utilization. At higher concentrations, oxidation of both substrates was appreciably diminished.
EFFECT OF SALICYLATE ON OXIDATIVE PHOSPHORYLATION illustrated in
Effect Jeffrey & Smith (1959) . In both tissues, regardless of the substrate, increasing concentrations of salicylate produced a progressive decrease in phosphate uptake and a concomitant decrease in the P/O ratio. In all instances, oxidative phosphorylation was completely uncoupled at a concentration of 10mM. At this concentration the adenosine-triphosphatase activity became apparent, as is indicated by an increase in the total inorganic phosphate in the system. The increase in inorganic phosphate was probably a consequence of the hydrolysis of exogenous ATP.
The results obtained from fragment studies on oxidative phosphorylation also indicate that salicylate, in contrast with Ca2+ and thyroxine, uncouples this type of sonically treated preparation. Again, increasing concentrations of salicylate produce a progressive decrease in phosphate uptake and in P/O ratio. It appears that the fragments are more sensitive to the uncoupling action of salicylate because they are completely uncoupled by a concentration of 1 mm, rather than 1OmM required for a similar effect in intact mitochondria. The difference in sensitivity to salicylate may be more apparent than real because several factors may be involved. First, if the intact mitochondrial membrane acts as a barrier through which salicylate must pass before any action occurs, disruption ofthe membrane would make the receptor sites more accessible, thereby accounting for the increase in sensitivity in the fragments. Secondly, the mitochondrial and fragment preparations are not necessarily equivalent in terms of total number of reaction sites. The yield of fragments from sonically treated mitochondria is not known. Further, it has been reported that the sonically prepared fragments possess only the first two phosphorylation sites (McMurray et al. 1958; Kielley & Bronk, 1958; Gregg, 1963) . In addition, of the two phosphorylating sites present in the fragments, site 2 apparently contributes the greater portion of the phosphate incorporation (McMurray et al. 1958 ; Kielley & Bronk, 1958; Gregg, 1963) . This fact, combined with the report by Penniall (1958) that site 2 is the most vulnerable to the uncoupling action of salicylate, provides another possible explanation for the increase in sensitivity of the mitochondrial fragments to the uncoupling action of salicylate.
The ability of salicylate to uncouple mitochondrial fragments indicates that the uncoupling effect is not necessarily dependent on the intact mitochondrial membrane. In this respect salicylate action in these preparations is similar to that of dinitrophenol, but may differ from that of Ca2+ and thyroxine. These uncoupling agents do not uncouple oxidative phosphorylation in all fragment preparations reported. Different preparative procedures apparently result in different responses to Ca2+ and thyroxine (Cooper & Lehninger, 1956; Kielley & Bronk, 1957; Park, Meriwether & Park, 1958; McMurray et al. 1958; Penefsky, Pullman, Datta & Racker, 1960; Gregg, 1963) . Variability in the uncoupling effect of dinitrophenol, however, has not been reported. The preparation described in the present work is not uncoupled by thyroxine, but is uncoupled by salicylate. Therefore, on the basis of common effects on swelling, on ability to affect the entire respiratory chain, and on uncoupling mitochondrial fragments, salicylate resembles 197 Table 4 , appear to be extremely complex. A toxic dose of salicylate in vivo characteristically produces stimulation followed by depression of respiration. A similar effect is seen with increasing salicylate concentrations in both liver and brain homogenates metabolizing certain substrates; a concentration of 10mM, which completely uncouples oxidative phosphorylation in mitochondria, markedly stimulates the respiratory rate of liver and brain homogenates respiring on pyruvate (T. S.
Sulkowski & R. Karler, unpublished work). Under identical conditions, the respiratory rate of isolated brain mitochondria also increases, but that of liver mitochondria decreases greatly. Therefore it appears that, at least with liver, extramitochondrial factors may be involved in determining the effect of salicylate on respiration. In addition, the substrate also appears to influence the effect on respiration (Nitzescu & Cosma, 1923) . Brain mitochondrial respiration is stimulated when pyruvate is the substrate, but it is depressed when succinate or hydroxybutyrate is used.
From the studies of the effect of salicylate on the respiratory rate of tissue homogenates and isolated mitochondria, it is difficult to determine the direct effect on the respiratory chain. The use of mitochondrial fragments oxidizing NADH, however, provides an opportunity to determine the direct effect ofsalicylate on the electron-transport complex. These studies indicate that the effects observed do not necessarily coincide with those observed in intact mitochondria or in fragments metabolizing substrates other than NADH. For example, salicylate does little to the respiratory rate of liver fragments oxidizing NADH; however, respiration in the presence of succinate is markedly depressed and in the presence of ,B-hydroxybutyrate is stimulated at low doses and depressed at high concentrations. In contrast with liver fragments, brain fragments respiring on NADH are depressed. Therefore the direct effect of salicylate on the electron-transport reactions is different in the two tissues studied.
In general the effect of salicylate on respiration in vitro is obviously complex. The final effect may be the resultant of an interaction of a multiplicity of factors, such as the tissue, the substrate, mitochondrial and extramitochondrial influences, and the direct effect on the respiratory chain itself.
